Paper8599877
Effects of granisetron with doxorubicin or epirubicin on ECG intervals.
Jantunen IT and 3 others. Cancer Chemother Pharmacol, 1996. Cited by 37 papers, by iCite.
Cite this record
ConductScience Library. Effects of granisetron with doxorubicin or epirubicin on ECG intervals. Papers, record 8599877. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8599877
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antiemetics | Major topic |
| Doxorubicin | Major topic |
| Electrocardiography | Major topic |
| Epirubicin | Major topic |
| Granisetron | Major topic |
| Adult | |
| Aged | |
| Antibiotics, Antineoplastic | |
| Drug Interactions | |
| Female | |
| Heart Rate | |
| Humans | |
| Injections, Intravenous | |
| Male | |
| Middle Aged | |
| Neoplasms | |
| Serotonin Antagonists |
Source PubMed
References8
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 8120559 | A randomized, double-blind comparison of intravenous ondansetron alone and in combination with intravenous dexamethasone in the prevention of high-dose cisplatin-induced emesis. | J Clin Oncol | 1994 | https://conductscience.org/library/papers/8120559 | PubMed |
| 2 | 1678781 | Cardiac disturbances during the administration of taxol. | J Clin Oncol | 1991 | https://conductscience.org/library/papers/1678781 | PubMed |
| 3 | 2466960 | Continuous ambulatory ECG monitoring during fluorouracil therapy: a prospective study. | J Clin Oncol | 1989 | https://conductscience.org/library/papers/2466960 | PubMed |
| 4 | 2169778 | The clinical pharmacology of granisetron (BRL 43694), a novel specific 5-HT3 antagonist. | Eur J Cancer | 1990 | https://conductscience.org/library/papers/2169778 | PubMed |
| 5 | 8164028 | Dose-ranging evaluation of the serotonin antagonist dolasetron mesylate in patients receiving high-dose cisplatin. | J Clin Oncol | 1994 | https://conductscience.org/library/papers/8164028 | PubMed |
| 6 | 291473 | Sudden death during doxorubicin administration. | Cancer | 1979 | https://conductscience.org/library/papers/291473 | PubMed |
| 7 | 1985170 | Cisplatin-induced atrial fibrillation. | J Clin Oncol | 1991 | https://conductscience.org/library/papers/1985170 | PubMed |
| 8 | 1855280 | Double-blind, randomized crossover study of metoclopramide and batanopride for prevention of cisplatin-induced emesis. | Cancer Chemother Pharmacol | 1991 | https://conductscience.org/library/papers/1855280 | PubMed |
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 37 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 25834466 | Pharmacokinetics, safety, and efficacy of APF530 (extended-release granisetron) in patients receiving moderately or highly emetogenic chemotherapy: results of two Phase II trials. | Cancer Manag Res | 2015 | https://conductscience.org/library/papers/25834466 | PubMed |
| 24790242 | An evaluation of potential signals for ventricular arrhythmia and cardiac arrest with dolasetron, ondansetron, and granisetron in the fda combined spontaneous reporting system/adverse event reporting system. | Curr Ther Res Clin Exp | 2005 | https://conductscience.org/library/papers/24790242 | PubMed |
| 24741326 | A randomized, placebo-controlled, four-period crossover, definitive QT study of the effects of APF530 exposure, high-dose intravenous granisetron, and moxifloxacin on QTc prolongation. | Cancer Manag Res | 2014 | https://conductscience.org/library/papers/24741326 | PubMed |
| 23716765 | Comparative electrocardiographic effects of intravenous ondansetron and granisetron in patients undergoing surgery for carcinoma breast: A prospective single-blind randomised trial. | Indian J Anaesth | 2013 | https://conductscience.org/library/papers/23716765 | PubMed |
| 22241602 | Cardiac effects of granisetron in a prospective crossover randomized dose comparison trial. | Support Care Cancer | 2012 | https://conductscience.org/library/papers/22241602 | PubMed |
| 22170340 | Acute effect of palonosetron on electrocardiographic parameters in cancer patients: a prospective study. | Support Care Cancer | 2012 | https://conductscience.org/library/papers/22170340 | PubMed |
| 21773677 | Electrocardiographic findings of palonosetron in cancer patients. | Support Care Cancer | 2012 | https://conductscience.org/library/papers/21773677 | PubMed |
| 21356241 | Therapeutics of 5-HT3 receptor antagonists: current uses and future directions. | Pharmacol Ther | 2011 | https://conductscience.org/library/papers/21356241 | PubMed |
| 18239945 | The acute effect of tropisetron on ECG parameters in cancer patients. | Support Care Cancer | 2008 | https://conductscience.org/library/papers/18239945 | PubMed |
| 12608887 | Benefits and risks of newer treatments for chemotherapy-induced and postoperative nausea and vomiting. | Drug Saf | 2003 | https://conductscience.org/library/papers/12608887 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8599877
GET https://conductscience.org/api/papers/v1/8599877/authors